Back
Arcturus Therapeutics Holdings Stock Price Chart
Sponsored
ARCT
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
38
ARCT
Arcturus Therapeutics Holdings
Last Price:
18.25
Seasonality Move:
9.45%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.
Arcturus Therapeutics Holdings Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.42 | Sell |
20-day SMA: | 19.68 | Sell |
50-day SMA: | 20.68 | Sell |
200-day SMA: | 27.62 | Sell |
8-day EMA: | 18.5 | Sell |
20-day EMA: | 19.5 | Sell |
50-day EMA: | 20.7 | Sell |
200-day EMA: | 24.74 | Sell |
Arcturus Therapeutics Holdings Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 38.3 | Sell |
Chaikin Money Flow: | -183326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.41 - 22.73) | Sell |
Bollinger Bands (100): | (19.25 - 24.25) | Sell |
Arcturus Therapeutics Holdings Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arcturus Therapeutics Holdings Stock
Is Arcturus Therapeutics Holdings Stock a Buy?
- Arcturus Therapeutics Holdings share price is 18.33 while ARCT 8-day simple moving average is 18.42, which is a Sell signal.
- The stock price of ARCT is 18.33 while Arcturus Therapeutics Holdings 20-day SMA is 19.68, which makes it a Sell.
- Arcturus Therapeutics Holdings 50-day simple moving average is 20.68 while ARCT share price is 18.33, making it a Sell technically.
- ARCT stock price is 18.33 and Arcturus Therapeutics Holdings 200-day simple moving average is 27.62, creating a Sell signal.
ARCT Technical Analysis vs Fundamental Analysis
Sell
38
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy or a Sell?
-
Arcturus Therapeutics Holdings stock is rated a Sell
The current Arcturus Therapeutics Holdings [ARCT] share price is $18.33. The Score for ARCT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Arcturus Therapeutics Holdings Stock Info
Market Cap:
495.68M
Price in USD:
18.33
Share Volume:
777.9K
Arcturus Therapeutics Holdings 52-Week Range
52-Week High:
45.00
52-Week Low:
17.26
Sell
38
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Arcturus Therapeutics Holdings Share Price Forecast
-
What is the Arcturus Therapeutics Holdings stock price today?
The Arcturus Therapeutics Holdings stock price is 18.33 USD today. -
Will ARCT stock go up or go down?
Arcturus Therapeutics Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Arcturus Therapeutics Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcturus Therapeutics Holdings is overvalued.
Is Arcturus Therapeutics Holdings Stock a Buy?
- Arcturus Therapeutics Holdings share price is 18.33 while ARCT 8-day exponential moving average is 18.50, which is a Sell signal.
- The stock price of ARCT is 18.33 while Arcturus Therapeutics Holdings 20-day EMA is 19.50, which makes it a Sell.
- Arcturus Therapeutics Holdings 50-day exponential moving average is 20.70 while ARCT share price is 18.33, making it a Sell technically.
- ARCT stock price is 18.33 and Arcturus Therapeutics Holdings 200-day simple moving average is 24.74, creating a Sell signal.
Fundamental Analysis of Arcturus Therapeutics Holdings
Is Arcturus Therapeutics Holdings a good investment?
- Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.
Technical Analysis of Arcturus Therapeutics Holdings
Should I short Arcturus Therapeutics Holdings stock?
- ARCT Moving Average Covergence Divergence (MACD) indicator is -0.95, suggesting Arcturus Therapeutics Holdings is a Sell
- Arcturus Therapeutics Holdings Relative Strength Index (RSI) is 38.3, which suggest Arcturus Therapeutics Holdings is oversold
- The Bollinger Bands (25) for Arcturus Therapeutics Holdings is (18.41 - 22.73), which suggest Arcturus Therapeutics Holdings is a Sell
- The Bollinger Bands (100) for Arcturus Therapeutics Holdings is (19.25 - 24.25), which suggest Arcturus Therapeutics Holdings is a Sell
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.